TIM-3 expression was found to be higher on peripheral NK cells from glioma patients than on those from healthy controls, and these TIM-3+ NK cells showed a reduced capability for IFN-γ production and correlated with the proportion of Ki-67+ tumor cells (113). This evidence concerns the gene HAVCR2 and glioma.